This week on Contemporary OB/GYN®: August 16 to August 20
Here's what to look for this week on Contemporary OB/GYN®.
You can expect a variety of topics this week, including:
FDA accepts pembrolizumab as singlea agent for treatment of advanded endometrial cancer
New biomarker could predict immunotherapy benefit in breast cancer
New Hampshire's abortion restrictions
Oral contraceptives and risk of cardiac events in women with congenital long-QT syndrome
The impact of nutrition on gynecological diseases
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More
